AdaptHealth/$AHCO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About AdaptHealth
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.
Ticker
$AHCO
Sector
Primary listing
Industry
Health Care Providers and Services
Headquarters
Employees
10,500
Website
AdaptHealth Metrics
BasicAdvanced
$1.3B
16.60
$0.58
1.64
-
Price and volume
Market cap
$1.3B
Beta
1.64
52-week high
$11.73
52-week low
$7.11
Average daily volume
1.5M
Financial strength
Current ratio
1.292
Quick ratio
0.822
Long term debt to equity
129.769
Total debt to equity
133.638
Interest coverage (TTM)
2.23%
Profitability
EBITDA (TTM)
643.522
Gross margin (TTM)
22.55%
Net profit margin (TTM)
2.63%
Operating margin (TTM)
8.42%
Effective tax rate (TTM)
28.32%
Revenue per employee (TTM)
$310,000
Management effectiveness
Return on assets (TTM)
3.82%
Return on equity (TTM)
5.90%
Valuation
Price to earnings (TTM)
16.595
Price to revenue (TTM)
0.397
Price to book
0.8
Price to tangible book (TTM)
-1.09
Price to free cash flow (TTM)
4.688
Free cash flow yield (TTM)
21.33%
Free cash flow per share (TTM)
2.046
Growth
Revenue change (TTM)
-0.05%
Earnings per share change (TTM)
-110.91%
3-year revenue growth (CAGR)
6.48%
3-year earnings per share growth (CAGR)
-9.81%
What the Analysts think about AdaptHealth
Analyst ratings (Buy, Hold, Sell) for AdaptHealth stock.
Bulls say / Bears say
AdaptHealth achieved a net income of $90.4 million in 2024, a significant turnaround from a net loss of $678.9 million in 2023, indicating improved financial health. (adapthealth.com)
The company reported a 1.9% increase in net revenue in 2024, reaching $3.26 billion, reflecting steady growth. (adapthealth.com)
AdaptHealth's free cash flow increased to $235.8 million in 2024 from $143.2 million in 2023, enhancing its financial flexibility. (adapthealth.com)
The company's net revenue growth slowed to 1.9% in 2024 compared to 7.7% in 2023, indicating a deceleration in growth. (adapthealth.com)
Adjusted EBITDA growth was modest at 2.7% in 2024, suggesting limited improvement in operational efficiency. (adapthealth.com)
The company experienced a slight decrease in net revenue in Q4 2024 compared to Q4 2023, which could indicate potential challenges in maintaining growth momentum. (adapthealth.com)
Data summarised monthly by Lightyear AI. Last updated on 6 Jul 2025.
AdaptHealth Financial Performance
Revenues and expenses
AdaptHealth Earnings Performance
Company profitability
AdaptHealth News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for AdaptHealth stock?
AdaptHealth (AHCO) has a market cap of $1.3B as of July 30, 2025.
What is the P/E ratio for AdaptHealth stock?
The price to earnings (P/E) ratio for AdaptHealth (AHCO) stock is 16.6 as of July 30, 2025.
Does AdaptHealth stock pay dividends?
No, AdaptHealth (AHCO) stock does not pay dividends to its shareholders as of July 30, 2025.
When is the next AdaptHealth dividend payment date?
AdaptHealth (AHCO) stock does not pay dividends to its shareholders.
What is the beta indicator for AdaptHealth?
AdaptHealth (AHCO) has a beta rating of 1.64. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.